RxDoctor Payments Data

Katherine Saragosa, PA

Medical · Melrose, MANPI 1649379579

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.6% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Johnson & Johnson at 26.7% of the total. 2025 is the largest year on record at $1,626, more than ten times the $23 reported in 2021. Among medical clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,423in general payments, 2019–2025

Across 145 payments — averaging $23.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$915
  • E.r. Squibb & Sons, L.L.C.$559
  • AbbVie$405
  • Lilly USA, LLC$349
  • Pfizer$291
  • Incyte Corporation$193
  • plus $711 from 10 others

What the payments were for

  • Food & beverage$3,10191%
  • Education$3229%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,423 in reported general payments places this provider in the 90th percentile of 421 medical providers in Massachusetts.

See all medical providers in Massachusetts

Medicare billing

Part B allowed, 2024
$96,505
Medicare patients
432
Services billed
1,171

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole138$2,470
Tacrolimus12$1,989
Fluocinonide34$1,282
Metronidazole23$923
Triamcinolone Acetonide49$711
Fluorouracil13$581
CiclopiroxCiclopirox Olamine13$471
Ciclopirox12$371
Mometasone Furoate34$360
Mupirocin28$182
ValacyclovirValacyclovir Hcl11$55
Cephalexin11$30

Paid to pharmacies, not to this prescriber.

Other medical in Melrose

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →